Swot Analysis of "Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B)" written by Robert D. Landel, Rebecca Goldberg includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Uv5972 Wyeth facing as an external strategic factors. Some of the topics covered in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study are - Strategic Management Strategies, Operations management, Technology and Leadership & Managing People.
Some of the macro environment factors that can be used to understand the Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) casestudy better are - – wage bills are increasing, digital marketing is dominated by two big players Facebook and Google, increasing commodity prices, banking and financial system is disrupted by Bitcoin and other crypto currencies, increasing government debt because of Covid-19 spendings, increasing transportation and logistics costs, increasing inequality as vast percentage of new income is going to the top 1%,
central banks are concerned over increasing inflation, supply chains are disrupted by pandemic , etc
Introduction to SWOT Analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B)
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Uv5972 Wyeth, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Uv5972 Wyeth operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) can be done for the following purposes –
1. Strategic planning using facts provided in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study
2. Improving business portfolio management of Uv5972 Wyeth
3. Assessing feasibility of the new initiative in Leadership & Managing People field.
4. Making a Leadership & Managing People topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Uv5972 Wyeth
Strengths Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Uv5972 Wyeth in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study are -
High brand equity
– Uv5972 Wyeth has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Uv5972 Wyeth to keep acquiring new customers and building profitable relationship with both the new and loyal customers.
Analytics focus
– Uv5972 Wyeth is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Robert D. Landel, Rebecca Goldberg can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Learning organization
- Uv5972 Wyeth is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Uv5972 Wyeth is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study emphasize – knowledge, initiative, and innovation.
Cross disciplinary teams
– Horizontal connected teams at the Uv5972 Wyeth are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.
Diverse revenue streams
– Uv5972 Wyeth is present in almost all the verticals within the industry. This has provided firm in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.
High switching costs
– The high switching costs that Uv5972 Wyeth has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.
Ability to lead change in Leadership & Managing People field
– Uv5972 Wyeth is one of the leading players in its industry. Over the years it has not only transformed the business landscape in its segment but also across the whole industry. The ability to lead change has enabled Uv5972 Wyeth in – penetrating new markets, reaching out to new customers, and providing different value propositions to different customers in the international markets.
Successful track record of launching new products
– Uv5972 Wyeth has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Uv5972 Wyeth has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.
Superior customer experience
– The customer experience strategy of Uv5972 Wyeth in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.
Training and development
– Uv5972 Wyeth has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.
Digital Transformation in Leadership & Managing People segment
- digital transformation varies from industry to industry. For Uv5972 Wyeth digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Uv5972 Wyeth has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.
Innovation driven organization
– Uv5972 Wyeth is one of the most innovative firm in sector. Manager in Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.
Weaknesses Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) are -
Ability to respond to the competition
– As the decision making is very deliberative, highlighted in the case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), in the dynamic environment Uv5972 Wyeth has struggled to respond to the nimble upstart competition. Uv5972 Wyeth has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.
High operating costs
– Compare to the competitors, firm in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) has high operating costs in the. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Uv5972 Wyeth 's lucrative customers.
Interest costs
– Compare to the competition, Uv5972 Wyeth has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.
High dependence on existing supply chain
– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Uv5972 Wyeth supply chain. Even after few cautionary changes mentioned in the HBR case study - Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Uv5972 Wyeth vulnerable to further global disruptions in South East Asia.
Employees’ incomplete understanding of strategy
– From the instances in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), it seems that the employees of Uv5972 Wyeth don’t have comprehensive understanding of the firm’s strategy. This is reflected in number of promotional campaigns over the last few years that had mixed messaging and competing priorities. Some of the strategic activities and services promoted in the promotional campaigns were not consistent with the organization’s strategy.
Slow to strategic competitive environment developments
– As Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) HBR case study mentions - Uv5972 Wyeth takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the industry in last five years.
High bargaining power of channel partners
– Because of the regulatory requirements, Robert D. Landel, Rebecca Goldberg suggests that, Uv5972 Wyeth is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.
Products dominated business model
– Even though Uv5972 Wyeth has some of the most successful products in the industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. firm in the HBR case study - Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) should strive to include more intangible value offerings along with its core products and services.
Skills based hiring
– The stress on hiring functional specialists at Uv5972 Wyeth has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.
Capital Spending Reduction
– Even during the low interest decade, Uv5972 Wyeth has not been able to do capital spending to the tune of the competition. This has resulted into fewer innovations and company facing stiff competition from both existing competitors and new entrants who are disrupting the industry using digital technology.
High cash cycle compare to competitors
Uv5972 Wyeth has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.
Opportunities Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) are -
Loyalty marketing
– Uv5972 Wyeth has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.
Learning at scale
– Online learning technologies has now opened space for Uv5972 Wyeth to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.
Identify volunteer opportunities
– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Uv5972 Wyeth can explore opportunities that can attract volunteers and are consistent with its mission and vision.
Creating value in data economy
– The success of analytics program of Uv5972 Wyeth has opened avenues for new revenue streams for the organization in the industry. This can help Uv5972 Wyeth to build a more holistic ecosystem as suggested in the Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) case study. Uv5972 Wyeth can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.
Leveraging digital technologies
– Uv5972 Wyeth can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Reconfiguring business model
– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Uv5972 Wyeth to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.
Increase in government spending
– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Uv5972 Wyeth can use these opportunities to build new business models that can help the communities that Uv5972 Wyeth operates in. Secondly it can use opportunities from government spending in Leadership & Managing People sector.
Finding new ways to collaborate
– Covid-19 has not only transformed business models of companies in Leadership & Managing People industry, but it has also influenced the consumer preferences. Uv5972 Wyeth can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.
Building a culture of innovation
– managers at Uv5972 Wyeth can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Leadership & Managing People segment.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Uv5972 Wyeth to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Uv5972 Wyeth to hire the very best people irrespective of their geographical location.
Using analytics as competitive advantage
– Uv5972 Wyeth has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Uv5972 Wyeth to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.
Harnessing reconfiguration of the global supply chains
– As the trade war between US and China heats up in the coming years, Uv5972 Wyeth can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help, as suggested in case study, Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.
Reforming the budgeting process
- By establishing new metrics that will be used to evaluate both existing and potential projects Uv5972 Wyeth can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.
Threats Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) are -
Trade war between China and United States
– The trade war between two of the biggest economies can hugely impact the opportunities for Uv5972 Wyeth in the Leadership & Managing People industry. The Leadership & Managing People industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.
Technology acceleration in Forth Industrial Revolution
– Uv5972 Wyeth has witnessed rapid integration of technology during Covid-19 in the Leadership & Managing People industry. As one of the leading players in the industry, Uv5972 Wyeth needs to keep up with the evolution of technology in the Leadership & Managing People sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.
Learning curve for new practices
– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B), Uv5972 Wyeth may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Leadership & Managing People .
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Uv5972 Wyeth business can come under increasing regulations regarding data privacy, data security, etc.
High level of anxiety and lack of motivation
– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Uv5972 Wyeth needs to understand the core reasons impacting the Leadership & Managing People industry. This will help it in building a better workplace.
High dependence on third party suppliers
– Uv5972 Wyeth high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.
Regulatory challenges
– Uv5972 Wyeth needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Leadership & Managing People industry regulations.
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Uv5972 Wyeth.
Stagnating economy with rate increase
– Uv5972 Wyeth can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.
Instability in the European markets
– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Uv5972 Wyeth will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.
Consumer confidence and its impact on Uv5972 Wyeth demand
– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.
Increasing wage structure of Uv5972 Wyeth
– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Uv5972 Wyeth.
Environmental challenges
– Uv5972 Wyeth needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Uv5972 Wyeth can take advantage of this fund but it will also bring new competitors in the Leadership & Managing People industry.
Weighted SWOT Analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of Wyeth Pharmaceuticals in 2009: Transformation at the Site Level (B) is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Uv5972 Wyeth needs to make to build a sustainable competitive advantage.
